Using a Global Systematic Framework Tool to Identify Pharmacy Workforce Development Needs: A National Case Study on Saudi Arabia
Background: Healthcare is one of the key focuses of the Saudi Vision 2030. Identifying and acknowledging the strengths and weakness of the healthcare manpower, including pharmacy, are crucial for workforce development and for achievement of the vision. Methods: This paper used a global systematic fr...
Saved in:
Published in | Risk management and healthcare policy Vol. 14; pp. 3233 - 3245 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Macclesfield
Dove Medical Press Limited
01.01.2021
Taylor & Francis Ltd Dove Dove Medical Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Healthcare is one of the key focuses of the Saudi Vision 2030. Identifying and acknowledging the strengths and weakness of the healthcare manpower, including pharmacy, are crucial for workforce development and for achievement of the vision. Methods: This paper used a global systematic framework tool, the International Pharmaceutical Federation the International 21 Development Goals (FIP DGs), as a roadmap to identify pharmacy workforce development needs. Results: An increase in the number of qualified Saudi pharmacy employees was successfully achieved by increasing the number of pharmacy education institutions. Several postgraduate pharmacy programs (Master's and Ph.D.) were also established. Some pharmacy colleges around the country obtained national and international accreditation/certification from reputable quality assurance organizations, such as the NAAA, ACPE and CCAPP. Clinical pharmacy residency programs were expanded to cover various specialties. No comprehensive competency framework exists for pharmacists in Saudi Arabia. A wide range of CDP programs, including electronic courses, have been offered for healthcare practitioners and accredited by SCFHS. While a certain number of CME hours are required for re-registration as a pharmacist, these CME hours are currently not linked to a needs-based health initiative. Several initiatives and strategies have been developed and implemented to address pharmaceutical workforce gender and diversity balances. The pharmacy profession is regulated by the MOH, the SCFHS, and the HRSD. Discussion and Conclusion: Among the three clusters of the DGs--Academia, Professional Development, and Systems--Cluster 2, Professional Development, was identified as a priority area for improvement. Within this cluster, these particular DGs were selected as top priority: competency development (DG 5), leadership development (DG 6), and working with others (DG 8). Two DGs in Cluster 3, Systems, were also highlighted as priorities: continuing professional development strategies (DG 9) and impact and outcome (DG 11). Keywords: pharmacy workforce, Saudi Arabia, FIP development goals |
---|---|
AbstractList | Background: Healthcare is one of the key focuses of the Saudi Vision 2030. Identifying and acknowledging the strengths and weakness of the healthcare manpower, including pharmacy, are crucial for workforce development and for achievement of the vision. Methods: This paper used a global systematic framework tool, the International Pharmaceutical Federation the International 21 Development Goals (FIP DGs), as a roadmap to identify pharmacy workforce development needs. Results: An increase in the number of qualified Saudi pharmacy employees was successfully achieved by increasing the number of pharmacy education institutions. Several postgraduate pharmacy programs (Master’s and Ph.D.) were also established. Some pharmacy colleges around the country obtained national and international accreditation/certification from reputable quality assurance organizations, such as the NAAA, ACPE and CCAPP. Clinical pharmacy residency programs were expanded to cover various specialties. No comprehensive competency framework exists for pharmacists in Saudi Arabia. A wide range of CDP programs, including electronic courses, have been offered for healthcare practitioners and accredited by SCFHS. While a certain number of CME hours are required for re-registration as a pharmacist, these CME hours are currently not linked to a needs-based health initiative. Several initiatives and strategies have been developed and implemented to address pharmaceutical workforce gender and diversity balances. The pharmacy profession is regulated by the MOH, the SCFHS, and the HRSD. Discussion and Conclusion: Among the three clusters of the DGs – Academia, Professional Development, and Systems – Cluster 2, Professional Development, was identified as a priority area for improvement. Within this cluster, these particular DGs were selected as top priority: competency development (DG 5), leadership development (DG 6), and working with others (DG 8). Two DGs in Cluster 3, Systems, were also highlighted as priorities: continuing professional development strategies (DG 9) and impact and outcome (DG 11). BACKGROUNDHealthcare is one of the key focuses of the Saudi Vision 2030. Identifying and acknowledging the strengths and weakness of the healthcare manpower, including pharmacy, are crucial for workforce development and for achievement of the vision. METHODSThis paper used a global systematic framework tool, the International Pharmaceutical Federation the International 21 Development Goals (FIP DGs), as a roadmap to identify pharmacy workforce development needs. RESULTSAn increase in the number of qualified Saudi pharmacy employees was successfully achieved by increasing the number of pharmacy education institutions. Several postgraduate pharmacy programs (Master's and Ph.D.) were also established. Some pharmacy colleges around the country obtained national and international accreditation/certification from reputable quality assurance organizations, such as the NAAA, ACPE and CCAPP. Clinical pharmacy residency programs were expanded to cover various specialties. No comprehensive competency framework exists for pharmacists in Saudi Arabia. A wide range of CDP programs, including electronic courses, have been offered for healthcare practitioners and accredited by SCFHS. While a certain number of CME hours are required for re-registration as a pharmacist, these CME hours are currently not linked to a needs-based health initiative. Several initiatives and strategies have been developed and implemented to address pharmaceutical workforce gender and diversity balances. The pharmacy profession is regulated by the MOH, the SCFHS, and the HRSD. DISCUSSION AND CONCLUSIONAmong the three clusters of the DGs - Academia, Professional Development, and Systems - Cluster 2, Professional Development, was identified as a priority area for improvement. Within this cluster, these particular DGs were selected as top priority: competency development (DG 5), leadership development (DG 6), and working with others (DG 8). Two DGs in Cluster 3, Systems, were also highlighted as priorities: continuing professional development strategies (DG 9) and impact and outcome (DG 11). Dalia Almaghaslah,1 Abdulrhman Alsayari2 1Department of Clinical Pharmacy, King Khalid University, Abha, Saudi Arabia; 2Department of Pharmacognosy, King Khalid University, Abha, Saudi ArabiaCorrespondence: Dalia AlmaghaslahCollege of Pharmacy, King Khalid University, PO Box 1882, Abha, 61441, Saudi ArabiaEmail damoazle@kku.edu.saBackground: Healthcare is one of the key focuses of the Saudi Vision 2030. Identifying and acknowledging the strengths and weakness of the healthcare manpower, including pharmacy, are crucial for workforce development and for achievement of the vision.Methods: This paper used a global systematic framework tool, the International Pharmaceutical Federation the International 21 Development Goals (FIP DGs), as a roadmap to identify pharmacy workforce development needs.Results: An increase in the number of qualified Saudi pharmacy employees was successfully achieved by increasing the number of pharmacy education institutions. Several postgraduate pharmacy programs (Master’s and Ph.D.) were also established. Some pharmacy colleges around the country obtained national and international accreditation/certification from reputable quality assurance organizations, such as the NAAA, ACPE and CCAPP. Clinical pharmacy residency programs were expanded to cover various specialties. No comprehensive competency framework exists for pharmacists in Saudi Arabia. A wide range of CDP programs, including electronic courses, have been offered for healthcare practitioners and accredited by SCFHS. While a certain number of CME hours are required for re-registration as a pharmacist, these CME hours are currently not linked to a needs-based health initiative. Several initiatives and strategies have been developed and implemented to address pharmaceutical workforce gender and diversity balances. The pharmacy profession is regulated by the MOH, the SCFHS, and the HRSD.Discussion and Conclusion: Among the three clusters of the DGs – Academia, Professional Development, and Systems – Cluster 2, Professional Development, was identified as a priority area for improvement. Within this cluster, these particular DGs were selected as top priority: competency development (DG 5), leadership development (DG 6), and working with others (DG 8). Two DGs in Cluster 3, Systems, were also highlighted as priorities: continuing professional development strategies (DG 9) and impact and outcome (DG 11).Keywords: pharmacy workforce, Saudi Arabia, FIP development goals Background: Healthcare is one of the key focuses of the Saudi Vision 2030. Identifying and acknowledging the strengths and weakness of the healthcare manpower, including pharmacy, are crucial for workforce development and for achievement of the vision. Methods: This paper used a global systematic framework tool, the International Pharmaceutical Federation the International 21 Development Goals (FIP DGs), as a roadmap to identify pharmacy workforce development needs. Results: An increase in the number of qualified Saudi pharmacy employees was successfully achieved by increasing the number of pharmacy education institutions. Several postgraduate pharmacy programs (Master's and Ph.D.) were also established. Some pharmacy colleges around the country obtained national and international accreditation/certification from reputable quality assurance organizations, such as the NAAA, ACPE and CCAPP. Clinical pharmacy residency programs were expanded to cover various specialties. No comprehensive competency framework exists for pharmacists in Saudi Arabia. A wide range of CDP programs, including electronic courses, have been offered for healthcare practitioners and accredited by SCFHS. While a certain number of CME hours are required for re-registration as a pharmacist, these CME hours are currently not linked to a needs-based health initiative. Several initiatives and strategies have been developed and implemented to address pharmaceutical workforce gender and diversity balances. The pharmacy profession is regulated by the MOH, the SCFHS, and the HRSD. Discussion and Conclusion: Among the three clusters of the DGs--Academia, Professional Development, and Systems--Cluster 2, Professional Development, was identified as a priority area for improvement. Within this cluster, these particular DGs were selected as top priority: competency development (DG 5), leadership development (DG 6), and working with others (DG 8). Two DGs in Cluster 3, Systems, were also highlighted as priorities: continuing professional development strategies (DG 9) and impact and outcome (DG 11). Keywords: pharmacy workforce, Saudi Arabia, FIP development goals |
Audience | Academic |
Author | Almaghaslah, Dalia Alsayari, Abdulrhman |
Author_xml | – sequence: 1 fullname: Almaghaslah, Dalia – sequence: 2 fullname: Alsayari, Abdulrhman |
BookMark | eNptks9v0zAUgCM0xMbYjT_AEhLiQIt_xjEHpKqwrdIYE93E0bKdlzYliYudDPXGn467VrAi7IOt58-f9Z7f8-yo8x1k2UuCx5Rw-e7r58ub8ZxRKqR8kp0QItWICMWPHu2Ps7MYVzgNrgpZyGfZMeNMMcHwSfbrLtbdAhl00XhrGjTfxB5a09cOnQfTwk8fvqNb7xvUezQroevraoNulia0xm3Qt3Rc-eAAfYR7aPy6TQS6BijjezRB10nku6Sdmgho3g_lBvkOzc1Q1mgSjK3Ni-xpZZoIZ_v1NLs7_3Q7vRxdfbmYTSdXIycE60cWV1Q6lxcKJC6pxIZaIcFwURCelzlVhVPSWpUTDNYYK6zNKUuAA6aAsNNstvOW3qz0OtStCRvtTa0fAj4stAkp7Qa0JDnOqcytrCwX4JTijmCnuOXAqgqS68POtR5sC6VLOQfTHEgPT7p6qRf-XhdMcCl5ErzZC4L_MUDsdVtHB01jOvBD1FTkRBGuiEzoq3_QlR9CqukDRbHkOBd_qYVJCdRd5dO7bivVk1wqRTmh22fH_6HSLKGtXeqsqk7xgwuvH11Ygmn6ZfTNsP3VeAi-3YEu-BgDVH-KQbDedqredqredyr7DSBX2ds |
CitedBy_id | crossref_primary_10_3390_healthcare11142060 crossref_primary_10_3390_pharmacy11040127 crossref_primary_10_2147_RMHP_S443325 crossref_primary_10_1186_s40545_023_00602_8 crossref_primary_10_3389_fpubh_2023_1092215 crossref_primary_10_3390_ijerph20021635 crossref_primary_10_3390_healthcare10071264 crossref_primary_10_2147_IPRP_S441142 crossref_primary_10_1016_j_jsps_2024_102083 crossref_primary_10_2147_AMEP_S375929 crossref_primary_10_1016_j_jsps_2022_05_007 crossref_primary_10_1007_s11845_023_03455_x crossref_primary_10_3389_fpubh_2022_771308 crossref_primary_10_4103_jfmpc_jfmpc_1117_23 crossref_primary_10_3390_healthcare10050806 crossref_primary_10_3389_fphar_2023_1219528 |
Cites_doi | 10.3390/pharmacy6030060 10.1007/s11096-017-0568-6 10.1002/jac5.1239 10.1016/j.sapharm.2021.03.003 10.4212/cjhp.v69i3.1561 10.5688/ajpe77119 10.19080/jpcr.2016.01.555563 10.1016/j.jsps.2011.03.001 10.1186/s12960-018-0294-8 10.2147/AMEP.S226477 10.3390/ijerph18094589 10.1589/jpts.28.1142 10.31557/APJCP.2020.21.2.531 10.5688/ajpe5980 10.1186/s12913-015-1220-6 10.1002/hpm.2674 10.1016/j.sapharm.2020.08.008 10.1016/j.jtumed.2016.10.008 10.5688/ajpe7610205 10.12669/pjms.36.4.2214 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 Dove Medical Press Limited 2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 Almaghaslah and Alsayari. 2021 Almaghaslah and Alsayari. |
Copyright_xml | – notice: COPYRIGHT 2021 Dove Medical Press Limited – notice: 2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 Almaghaslah and Alsayari. 2021 Almaghaslah and Alsayari. |
DBID | AAYXX CITATION 3V. 7RV 7TQ 7XB 88C 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DHY DON DWQXO FYUFA GHDGH GNUQQ GUQSH KB0 M0T M2O MBDVC NAPCQ PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.2147/RMHP.S322577 |
DatabaseName | CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database PAIS Index ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College PAIS International PAIS International (Ovid) ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep Nursing & Allied Health Database (Alumni Edition) Healthcare Administration Database Research Library Research Library (Corporate) Nursing & Allied Health Premium ProQuest - Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection ProQuest Central Korea ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest One Academic UKI Edition PAIS International ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Business Education Philosophy |
DocumentTitleAlternate | Almaghaslah and Alsayari |
EISSN | 1179-1594 |
EndPage | 3245 |
ExternalDocumentID | oai_doaj_org_article_71606276b7fb45ec994c10c94b4e3ffe A679924124 10_2147_RMHP_S322577 |
GeographicLocations | Saudi Arabia |
GeographicLocations_xml | – name: Saudi Arabia |
GrantInformation_xml | – fundername: ; |
GroupedDBID | --- 0YH 29P 2WC 44B 53G 5VS 7RV 8C1 8FI 8FJ 8G5 AAYXX ABUWG ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AQUVI AZQEC BAWUL BCNDV BENPR BKEYQ BPHCQ BVXVI CCPQU CITATION DIK DWQXO E3Z EBD EBS EJD FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HYE IAO IHR IHW IPNFZ ITC KQ8 M0T M2O M48 M~E NAPCQ OK1 P2P PGMZT PIMPY PQQKQ PROAC RIG RPM TDBHL UKHRP VDV 3V. 7TQ 7XB 8FK DHY DON MBDVC PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c553t-b0f27cc689e70d270a2b57ea458146d6298c97bb9610ebaab5bb623ea4ce39e13 |
IEDL.DBID | RPM |
ISSN | 1179-1594 |
IngestDate | Thu Jul 04 20:50:29 EDT 2024 Tue Sep 17 20:43:49 EDT 2024 Fri Aug 16 04:29:18 EDT 2024 Tue Sep 17 12:29:21 EDT 2024 Fri Feb 23 00:01:50 EST 2024 Wed Oct 25 09:33:27 EDT 2023 Tue Aug 20 22:07:45 EDT 2024 Fri Aug 23 01:23:19 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c553t-b0f27cc689e70d270a2b57ea458146d6298c97bb9610ebaab5bb623ea4ce39e13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-3094-0808 0000-0002-5479-9319 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354774/ |
PMID | 34393530 |
PQID | 2562074065 |
PQPubID | 3933278 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_71606276b7fb45ec994c10c94b4e3ffe pubmedcentral_primary_oai_pubmedcentral_nih_gov_8354774 proquest_miscellaneous_2561914917 proquest_journals_2562074065 gale_infotracmisc_A679924124 gale_infotracacademiconefile_A679924124 gale_healthsolutions_A679924124 crossref_primary_10_2147_RMHP_S322577 |
PublicationCentury | 2000 |
PublicationDate | 2021-01-01 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Macclesfield |
PublicationPlace_xml | – name: Macclesfield |
PublicationTitle | Risk management and healthcare policy |
PublicationYear | 2021 |
Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove – name: Dove Medical Press |
References | ref34 ref15 Fallatah (ref36) 2016; 11 Aljadhey (ref13) 2013; 77 Alomi (ref31) 2016; 1 Alkhateeb (ref26) 2018; 82 ref30 ref33 AlAhmari (ref39) 2019; 10 ref32 ref2 Alaqeel (ref43) 2015; 15 ref17 ref16 ref19 ref18 AlRuthia (ref35) 2018; 16 Zamil (ref38) 2020; 36 Aljadhey (ref12) 2012; 76 Almaghaslah (ref1) 2018; 34 ref24 Kabel (ref40) 2020; 21 Cheema (ref10) 2018; 6 ref23 ref45 Al-Dhawailie (ref41) 2011; 19 ref25 ref20 Al-Haqan (ref3) 2021; 17 ref22 ref44 Al-jedai (ref14) 2016; 69 ref21 Badreldin (ref9) 2020 Abdulghani (ref42) 2018; 40 ref28 ref27 ref29 ref7 ref4 Almaghaslah (ref46) 2021; 18 ref6 ref5 Meilianti (ref8) 2021 Almaghaslah (ref11) 2019; 19 Al-Eisa (ref37) 2016; 28 |
References_xml | – volume: 6 start-page: 60 year: 2018 ident: ref10 publication-title: Pharmacy doi: 10.3390/pharmacy6030060 contributor: fullname: Cheema – ident: ref5 – ident: ref7 – ident: ref20 – ident: ref45 – ident: ref29 – ident: ref24 – ident: ref22 – ident: ref25 – ident: ref27 – volume: 40 start-page: 196 year: 2018 ident: ref42 publication-title: Int J Clin Pharm doi: 10.1007/s11096-017-0568-6 contributor: fullname: Abdulghani – year: 2020 ident: ref9 publication-title: J Am Coll Clin Pharm doi: 10.1002/jac5.1239 contributor: fullname: Badreldin – year: 2021 ident: ref8 publication-title: Res Soc Adm Pharm doi: 10.1016/j.sapharm.2021.03.003 contributor: fullname: Meilianti – volume: 69 year: 2016 ident: ref14 publication-title: Can J Hosp Pharm doi: 10.4212/cjhp.v69i3.1561 contributor: fullname: Al-jedai – volume: 77 start-page: 19 year: 2013 ident: ref13 publication-title: Am J Pharm Educ doi: 10.5688/ajpe77119 contributor: fullname: Aljadhey – ident: ref19 – ident: ref32 – volume: 19 start-page: 93 year: 2019 ident: ref11 publication-title: Pharm Educ contributor: fullname: Almaghaslah – volume: 1 start-page: 548 year: 2016 ident: ref31 publication-title: J Pharmacol Clin Res doi: 10.19080/jpcr.2016.01.555563 contributor: fullname: Alomi – volume: 19 start-page: 193 year: 2011 ident: ref41 publication-title: Saudi Pharm J doi: 10.1016/j.jsps.2011.03.001 contributor: fullname: Al-Dhawailie – ident: ref17 – ident: ref34 – ident: ref15 – ident: ref30 – volume: 16 year: 2018 ident: ref35 publication-title: Hum Resour Health doi: 10.1186/s12960-018-0294-8 contributor: fullname: AlRuthia – ident: ref4 – volume: 10 start-page: 1061 year: 2019 ident: ref39 publication-title: Adv Med Educ Pract doi: 10.2147/AMEP.S226477 contributor: fullname: AlAhmari – ident: ref2 – ident: ref6 – ident: ref44 – volume: 18 start-page: 4589 year: 2021 ident: ref46 publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph18094589 contributor: fullname: Almaghaslah – ident: ref28 – volume: 28 start-page: 1142 year: 2016 ident: ref37 publication-title: J Phys Ther Sci doi: 10.1589/jpts.28.1142 contributor: fullname: Al-Eisa – ident: ref21 – volume: 21 start-page: 531 year: 2020 ident: ref40 publication-title: Asian Pac J Cancer Prev doi: 10.31557/APJCP.2020.21.2.531 contributor: fullname: Kabel – ident: ref23 – volume: 82 start-page: 5980 year: 2018 ident: ref26 publication-title: Am J Pharm Educ doi: 10.5688/ajpe5980 contributor: fullname: Alkhateeb – volume: 15 start-page: 557 year: 2015 ident: ref43 publication-title: BMC Health Serv Res doi: 10.1186/s12913-015-1220-6 contributor: fullname: Alaqeel – volume: 34 year: 2018 ident: ref1 publication-title: Int J Health Plann Manage doi: 10.1002/hpm.2674 contributor: fullname: Almaghaslah – ident: ref18 – volume: 17 start-page: 1101 year: 2021 ident: ref3 publication-title: Res Soc Adm Pharm doi: 10.1016/j.sapharm.2020.08.008 contributor: fullname: Al-Haqan – volume: 11 start-page: 520 year: 2016 ident: ref36 publication-title: J Taibah Univ Med Sci doi: 10.1016/j.jtumed.2016.10.008 contributor: fullname: Fallatah – volume: 76 start-page: 205 year: 2012 ident: ref12 publication-title: Am J Pharm Educ doi: 10.5688/ajpe7610205 contributor: fullname: Aljadhey – ident: ref16 – volume: 36 year: 2020 ident: ref38 publication-title: Pak J Med Sci doi: 10.12669/pjms.36.4.2214 contributor: fullname: Zamil – ident: ref33 |
SSID | ssj0000498787 |
Score | 2.324445 |
Snippet | Background: Healthcare is one of the key focuses of the Saudi Vision 2030. Identifying and acknowledging the strengths and weakness of the healthcare manpower,... BACKGROUNDHealthcare is one of the key focuses of the Saudi Vision 2030. Identifying and acknowledging the strengths and weakness of the healthcare manpower,... Dalia Almaghaslah,1 Abdulrhman Alsayari2 1Department of Clinical Pharmacy, King Khalid University, Abha, Saudi Arabia; 2Department of Pharmacognosy, King... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database |
StartPage | 3233 |
SubjectTerms | Academic achievement Ambulatory care Case reports Case studies Certification Colleges & universities Continuing medical education Development strategies Drug stores Education Education parks Educational evaluation Employee development Employment Females fip development goals Health care Health care policy Health promotion Health services Hospitals Labor supply Licenses Manpower Original Research Pharmaceutical industry Pharmacists Pharmacy pharmacy workforce Philosophy Private sector Professional development Quality Quality assurance Registration saudi arabia School facilities Students Study abroad Workforce |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQD4gL4lMECgwSiFNoPuw45rZUrFZIVBXbSr1ZtjMRW1UJoruHvfHTmYmzqw0cuHCNJ5LjmfE8O8_PQrzNfa1C3uQp-dukspYyrRuZp1hh1mjjWFWL2RZn1eJSfrlSVwdXfTEnLMoDx4E7ITzPSrqV162XCoMxMuRZMNJLLNsWh9k3VweLqeuIe2tdjzermJRqtoysd76W5-Tb18X5hyWHstaTejTI9v89Of9JmDyoQPMH4v4IHWEWu_xQ3MHukbi7Y64_Fr-G3__gIOr4w3Iv0gzzHQULLvr-BtY9xAO67RbOo3b1FnjbnBBsQDggEsEZVbfbjzCDUUD7Bk6p7gHTD7fQd7B0m2ZFfXJ-5Z6Iy_nni9NFOl6wkAalynXqs7bQIVS1QZ01hc5c4ZVGJxVvDDZVYepgtPeGMBZ657zynuASGQQsDeblU3HU9R0-ExD4f6fKXNtKLWVZkG2J9CaNN2KOIRHvdsNsf0QdDUvrD3aHZXfY0R2J-MQ-2Nuw-vXwgGLCjjFh_xUTiXjNHrTxKOk-h-2s0obWmwRpEvF-sOAsJo8GNx5GoI9hPayJ5fHEkrIvTJt3UWLH7L-1BCMLgmaE7hLxZt_MbzKjrcN-M9iwtB6tlhOhJ9E1-fZpS7f6PiiA824d4fbn_2OwXoh7BfN0hm2lY3G0_rnBlwS01v7VkFO_AXDHJRM priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB6VVkK9IFhAhBYwEohT2DycOOaCtlVXKyRWq24r9RbZjgMrVUkf2cPe-OnMJE5oQOIaT5THzHjG48_fAHwIdZaYsAh91Lf0eca5nxU89G1qg0JIRaxahLZYpotL_u0qudqDRX8WhmCV_ZzYTtRFbahGPsXQHGG4w4g5VZqqAKaZfr259al_FO2zumYaj-AgCjlt2B6cnC1X50O9BTPhDI2zw75Tc57p-ffF6vOaDFqIUVRqyfv_naL_hk0-iEPzp_DEJZBs1mn8GezZagKPe_z6hNowO8jGBA5XfaOC3XP41aIDmGIdzT9bDxzObN4jtNhFXV-zpmbd-d1yx1YdtfWOUVUdE1xj2QOcEVti8Lv_wmbM8Wtfs1MMi4zQiTtWV2yttsUGX1bpjXoBl_Ozi9OF7_ov-CZJ4sbXQRkJY9JMWhEUkQhUpBNhFU-oblikkcyMFFpLTMGsVkonWmM2hQLGxtKG8UvYr-rKvgJmaDs0CVRZcsF5HKFsbPFOVIS1oTUefOz_f37T0WzkuDwhPeWkp9zpyYMTUs4gQ-TY7YX67kfufC3HJSCRL6dalJon1kjJTRgYyTW3cVlaD96RavPupOng4vksFRKXo5jxePCplSAnJ1NT7qwCfgzRZY0kj0eS6JxmPNybT-4mh_v8jyl78H4YpjsJ8FbZetvKEPMeLqY9ECOzG337eKTa_GwJwqmYh2n96_8__AgOIwLotPWkY9hv7rb2DWZYjX7rnOc3T_snmg priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEB9qBfFF_MRo1RUUn1LzsclmBZGzeBxCS_Fa6Nuyu5noyZHo9Q68N_90Z_JxNNYHX7OTkOzM3Pxm77e_BXgVuyLzcRmH5G8dykLKsChlHGKOUam0ZVUtZluc5LNz-fkiu9iD4bTRfgIv_9na8XlS56vl4a-f2w-U8O-ZxhxL9fbL8ez0cM6RqdQNuJnIVHKsH_dA_3uHgwtV9Cet6JBquOxY8NceMKpPrYz_9R_rvwmUVyrS9C7c6aGkmHS-vwd7WN-HWwOT_QH8bukAwopO11_Md6LNYjpQssRZ0yzFuhHdht1qK047Leut4GV0QrQexRVikTihanf5TkxEL6i9FEdUBwXTEbeiqcXcbsoFvZN1C_sQzqefzo5mYX_gQuizLF2HLqoS5X1eaFRRmajIJi5TaGXGC4VlnujCa-WcJsyFzlqXOUfwiQw8phrj9BHs102Nj0F4_v8zi2xVSSVlmpBtinQnzTdijD6A18M0mx-droahfoTdYdgdpndHAB_ZBzsbVsNuLzSrr6ZPLkM9H6st505VTmbotZY-jryWTmJaVRjAC_ag6baW7nLaTHKlqf8kiBPAm9aC44w86m2_OYE-hvWxRpYHI0vKRj8eHqLEDMFsCFYmBNUI7QXwcjfMdzLDrcZm09qw1B51zwGoUXSNvn08Ui--tYrgvHpHOP7Jfzz9KdxOmJbDq0jRAeyvVxt8Rrhq7Z63KfMHfPogxA priority: 102 providerName: Scholars Portal |
Title | Using a Global Systematic Framework Tool to Identify Pharmacy Workforce Development Needs: A National Case Study on Saudi Arabia |
URI | https://www.proquest.com/docview/2562074065/abstract/ https://search.proquest.com/docview/2561914917 https://pubmed.ncbi.nlm.nih.gov/PMC8354774 https://doaj.org/article/71606276b7fb45ec994c10c94b4e3ffe |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwEB1tFwlxQXyKwFKMBOKUNh9OHHPrVltVSK2q7a60nCLbdaCom6x220Nv_HRmnKRq4MYlh3osJZmZ-o3z5hngU6izxISr0Ed_S59nnPvZioe-TW2wElKRqhaxLebp9Jp_u0luTiBpe2Ecad_o9aDc3A7K9U_Hrby7NcOWJzZczMa0WYGwZdiDnojjoxL9Vw15M4zCmuROp_AML2fTxWBJkSvozL2YUzsq0Z6PViIn2P_v3_LfVMmjtWfyDJ42oJGN6pt7Die2fAGPW876S_jtPvwzxWoFf7Y8yDOzSUu-YldVtWHbitWtucWeLWrV6j2jDXPErsayIwoRm-O69vCVjVgjnb1hY1zxGBEP96wq2VLtVmu8J6XX6hVcTy6uxlO_OVrBN0kSb30dFJEwJs2kFcEqEoGKdCKs4gltCa7SSGZGCq0loiurldKJ1giU0MDYWNowfg2nZVXaN8AMfelMAlUUXHAeR2gbW5yJr97a0BoPPrevOb-rFTRyrDzIMzl5Jm8848E5-eBgQ7rX7ofq_kfeeD_H6o50lVMtCs0Ta6TkJgyM5JrbuCisBx_Ig3ndRHrI3nyUComVJoIZD744C8pf9KhRTRsCPgwpYXUszzqWmHemO9xGSd7k_UOOADJCUIa4zoOPh2GaSVy20lY7Z0OielgneyA60dV59u4IpoLT_m5C_-1_z3wHTyKi5bhdpDM43d7v7HvEVVvdh17wfYrXbBz24dH5xXxx2Xd7FHid8azv8uwPslYoqw |
link.rule.ids | 230,315,733,786,790,870,891,2115,12250,21416,24346,27957,27958,33301,33302,33779,33780,43614,43840,53827,53829,74371,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgSLAXBAVEYDAjgXgKy4cTx7ygUlEV2KqKdtLeLNtxoNKUjLV96Bt_OneOExaQeI0vysfd-c7nn39HyOtYF5mJyzgEfYuQFYyFRcni0OY2KrlQyKqFaIt5PjtnXy6yC19w23hYZTcnuom6bAzWyE8gNCcQ7iBifrj6GWLXKNxd9S00bpM7LIVAgyfFJ3FfY4HstwCDbPHu2JDn5NvZbPFuiUbM-SASOcL-f6flv6GSN2LP9AG575NGOm61_JDcsvWI3O0w6yNsvexhGiNyuOiaE-wfkV8OEUAVban96bLnbabTDpVFV01zSbcNbc_sVnu6aOms9xQr6ZDUGktvYIvoHALe5j0dU8-pfUknEAopIhL3tKnpUu3KNbys0mv1mJxPP60ms9D3XAhNlqXbUEdVwo3JC2F5VCY8UonOuFUsw1phmSeiMIJrLSDtslopnWkNGRQIGJsKG6dPyEHd1PYpoQa3QLNIVRXjjKUJyKYW7gRFWBtbE5A33f-XVy21hoQlCepJop6k11NAPqJyehkkxHYXmuvv0vuXhGUfEi7nmleaZdYIwUwcGcE0s2lV2YAco2ple7q0d2s5zrmAJShkOQF56yTQsUHVRvnzCfAxSJE1kDwaSIJDmuFwZz7STwgb-cd8A_KqH8Y7EeRW22bnZJBtDxbQAeEDsxt8-3CkXv9wpOBYwINU_tn_H35M7s1WZ6fy9PP863NymCBAx9WTjsjB9npnX0CGtdUvnRv9BjkpJTI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELaglapeUFlABAo1EohT2DycOOaCtqWr5bWKuq3Um2U7TlmpStru7mFv_HRmEic0IHGNJ8pjZjzj8edvCHkb6iwxYRH6oG_hs4wxPytY6NvUBgUXClm1EG0xT2cX7OtlcunwTysHq-zmxGaiLmqDNfIxhOYIwh1EzHHpYBH55-mnm1sfO0jhTqtrp_GQ7HKWJmDhu8en8_ysr7hALpyBebbod2zPMz77Mcs_LNCkOR_EpYa-_99J-m_g5L1IND0gj1wKSSetzh-TB7Yakb0OwT7CRswOtDEi-3nXqmD7hPxq8AFU0Zbony56Fmc67TBa9Lyur-m6pu0J3nJL85bcekuxrg4prrH0HtKIziH8rT7SCXUM29f0BAIjRXziltYVXahNsYSXVXqpnpKL6en5ycx3HRh8kyTx2tdBGXFj0kxYHhQRD1SkE24VS7ByWKSRyIzgWgtIwqxWSidaQz4FAsbGwobxM7JT1ZV9TqjBDdEkUGXJOGNxBLKxhTtBEdaG1njkXff_5U1LtCFhgYJ6kqgn6fTkkWNUTi-D9NjNhfruSjpvk7AIRPrlVPNSs8QaIZgJAyOYZjYuS-uRI1StbM-a9k4uJykXsCCFnMcj7xsJdHNQtVHutAJ8DBJmDSQPB5LgnmY43JmPdNPDSv4xZo-86YfxToS8VbbeNDLIvQfLaY_wgdkNvn04Ui1_NhThWM6DxP7F_x9-RPbAh-T3L_NvL8l-hGidprh0SHbWdxv7CtKttX7t_Og3XT4rCg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Using+a+Global+Systematic+Framework+Tool+to+Identify+Pharmacy+Workforce+Development+Needs%3A+A+National+Case+Study+on+Saudi+Arabia&rft.jtitle=Risk+management+and+healthcare+policy&rft.au=Almaghaslah%2C+Dalia&rft.au=Alsayari%2C+Abdulrhman&rft.date=2021-01-01&rft.issn=1179-1594&rft.eissn=1179-1594&rft.volume=14&rft.spage=3233&rft.epage=3245&rft_id=info:doi/10.2147%2FRMHP.S322577&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1179-1594&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1179-1594&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1179-1594&client=summon |